The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

(2018) Séverine Guiu et al.   BRITISH JOURNAL OF CANCER

FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome

(2018) Willemijne Schrijver et al.   Molecular Oncology

Nestin-positive microvessel density is an independent prognostic factor in breast cancer

(2017) Aleksandra Nowak et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6

(2017) Noritaka Yamaguchi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer

(2017) Kristi Krüger et al.   Scientific Reports

FOXA1 defines cancer cell specificity

(2016) G. Zhang et al.   Science Advances

FOXA1: a Promising Prognostic Marker in Breast Cancer

(2014) Qing Hu et al.   Asian Pacific Journal of Cancer Prevention

Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases

(2014) Y Horimoto et al.   BRITISH JOURNAL OF CANCER

Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer

(2014) Yuichi Hisamatsu et al.   Breast Cancer

FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer

(2013) Mai Kawase et al.   Breast Cancer

FOXA1 mutations in hormone-dependent cancers

(2013) Jessica L. L. Robinson et al.   Frontiers in Oncology

The mutational landscape of lethal castration-resistant prostate cancer

(2012) Catherine S. Grasso et al.   NATURE

Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of Tamoxifen-Treated Breast Cancer Patients

(2012) Nobuhiro Ijichi et al.   Hormones & Cancer

FOXA1 is an independent prognostic marker for ER-positive breast cancer

(2011) Rutika J. Mehta et al.   BREAST CANCER RESEARCH AND TREATMENT

FOXA1: master of steroid receptor function in cancer

(2011) Michael A Augello et al.   EMBO JOURNAL

Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer

(2011) F. Piras et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors

(2010) C. M. Robbins et al.   GENOME RESEARCH

FOXA1 in breast cancer

(2009) Harikrishna Nakshatri et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores

(2009) Foluso O Ademuyiwa et al.   MODERN PATHOLOGY

Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance

(2008) Hany Onsy Habashy et al.   EUROPEAN JOURNAL OF CANCER

Nestin is expressed in basal-like and triple negative breast cancers

(2008) S Parry et al.   JOURNAL OF CLINICAL PATHOLOGY